UE
Uy Ear Mizuho Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
19
Avg Return
Past Year
Past Year
14%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
75%
Neutral
25%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Maintained
| $175 |
32%
upside
| 1 | – |
–
| 12 Dec ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $33 |
44%
upside
| 1 | -25% |
0
%
| 9 Dec ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $19 |
265%
upside
| 1 | -24% |
0
%
| 2 Dec ‘25 1 month ago |
|
|
|
Neutral
Maintained
| $29 |
12%
upside
| 1 | – |
–
| 2 Dec ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $37 |
43%
upside
| 1 | +69% |
0
%
| 28 Nov ‘25 1 month ago |
|
|
|
Outperform
Upgraded
| $10 |
167%
upside
| 1 | -12% |
0
%
| 19 Nov ‘25 1 month ago |
|
|
|
Outperform
Upgraded
| $26 |
23%
upside
| 1 | -15% |
0
%
| 5 Nov ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $45 |
42%
upside
| 1 | +6.1% |
0
%
| 27 Oct ‘25 2 months ago |
|